Open-source automated insulin delivery shows comparable glycemic outcomes to a commercial hybrid closed-loop system in real-world type 1 pediatric diabetes care: a retrospective cohort study from British Columbia, Canada
Open-source automated insulin delivery shows promise for managing type 1 diabetes, though pediatric efficacy and safety data remain limited. This study aimed to compare real-world glycemic outcomes of open-source automated insulin delivery systems with hybrid closed-loop systems in youth with type 1 diabetes. This retr...